Get A Free Legal Consultation
- We fight to maximize your results
- No out-of-pocket costs
- Over $11.7 billion recovered for families



Studies show taking gabapentin (Neurontin®) for off-label uses can significantly increase the risk of dementia and cognitive impairment in patients. If you or a loved one was harmed, you may be eligible for compensation from a gabapentin lawsuit.
At Simmons Hanly Conroy, we’re dedicated to fighting for families affected by dangerous medications. Call (855) 264-6270 now to see if you may qualify for a gabapentin dementia lawsuit.
Used as an anti-seizure medication, Gabapentin is also frequently prescribed for off-label uses, including neck and back pain, hot flashes, and mood disorders like anxiety. However, researchers have raised concerns that broader use may increase the risk of cognitive decline.
One study found that patients with chronic low back pain who received 6 or more gabapentin prescriptions had a 29% increased risk of dementia and an 85% increased risk of mild cognitive impairment within a 10-year period.
Those who’ve been harmed may be able to file a Gabapentin lawsuit against the manufacturer for failing to warn about the potential danger.
Gabapentin Lawsuits at a Glance
At Simmons Hanly Conroy, we have over 25 years of experience standing up to powerful corporations that put consumers in harm’s way. Get a free case review to see if we can help you seek justice from a Pfizer Neurontin lawsuit.
While Gabapentin is approved by the U.S. Food and Drug Administration (FDA) for shingles-related nerve pain and epileptic seizures, it’s frequently prescribed for other conditions it wasn’t designed to treat. New research has shown that off-label use of gabapentin may have health consequences.
Repeated gabapentin use is linked to higher rates of dementia and mild cognitive impairment over time, as reported by Regional Anesthesia & Pain Medicine. The medication affects how nerve signals are transmitted in the brain, which may affect memory and other cognitive functions, especially with repeated use.
The study also found that the elevated risk was not limited to older adults. Individuals between the ages of 35 and 49 had more than twice the risk of dementia and more than three times the risk of mild cognitive impairment compared to those who did not take gabapentin.
Use of the drug has increased significantly in recent years, meaning many patients may be at risk of long-term neurological effects.
Gabapentin lawsuit eligibility revolves around someone taking the drug and suffering an injury that wasn’t listed on the warning label.
You may be eligible for a gabapentin lawsuit if you or a loved one:
State laws known as statutes of limitations limit how much time you have to take legal action. For that reason, it’s important to reach out to our team as soon as possible after a diagnosis.
At Simmons Hanly Conroy, our gabapentin lawsuit lawyers can help families in all 50 states seek compensation for dementia linked to the medication.
We have over 25 years of experience standing up to powerful companies like Pfizer and evening the playing field for those harmed, including by dangerous medications.
Our team has recovered over $11.7 billion total for clients nationwide.
There are no upfront costs or hourly fees to work with our gabapentin lawsuit attorneys. We only get paid if we secure compensation for you.
Call (855) 264-6270 now or fill out our contact form to get started with a free legal consultation.
When gabapentin is used to treat certain off-label health conditions, researchers have found an increased risk of dementia and cognitive impairment.
One study found that patients who received 6 or more prescriptions of gabapentin for low back pain were 89% more likely to develop mild cognitive impairment and 29% more likely to develop dementia.
Find out if you can file a gabapentin lawsuit for dementia. Get a free legal consultation now.
At this time, there isn’t a gabapentin class action lawsuit for dementia. Instead, gabapentin lawsuits are being filed on an individual basis by families nationwide.
This allows each case to be evaluated based on an individual’s specific diagnosis, degree of cognitive decline, and other factors that may affect potential gabapentin settlement and verdict amounts.
At Simons Hanly Conroy, there are no upfront costs or hourly fees to work with our lawyers for a gabapentin lawsuit. We work on a contingency-fee basis, which means you pay nothing unless we secure compensation for you.
Call (855) 264-6270 now to see if our gabapentin lawyers can fight for your family.